Clinical Trial Update: Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating rimegepant as a preemptive treatment for predictable trigger-induced migraines in adults in the United States; recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Trigger-induced Migraine

Drugs mentioned

• NURTEC ODT (RIMEGEPANT SULFATE)

Snippet

Sponsor: Medstar Health Research Institute | Conditions: Migraine, Trigger Induced Migraine | Phase 4 | Status: RECRUITING